145 related articles for article (PubMed ID: 10418592)
1. Carbon dye as an adjunct to isosulfan blue dye for sentinel lymph node dissection.
Lucci A; Turner RR; Morton DL
Surgery; 1999 Jul; 126(1):48-53. PubMed ID: 10418592
[TBL] [Abstract][Full Text] [Related]
2. Dynamic MR lymphangiography and carbon dye for sentinel lymph node detection: a solution for sentinel lymph node biopsy in mucosal head and neck cancer.
Nason RW; Torchia MG; Morales CM; Thliveris J
Head Neck; 2005 Apr; 27(4):333-8. PubMed ID: 15700295
[TBL] [Abstract][Full Text] [Related]
3. First report of lymphatic mapping with isosulfan blue dye and sentinel node biopsy in cervical cancer.
Medl M; Peters-Engl C; Schütz P; Vesely M; Sevelda P
Anticancer Res; 2000; 20(2B):1133-4. PubMed ID: 10810409
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracer compared to isosulfan blue.
Eldrageely K; Vargas MP; Khalkhali I; Venegas R; Burla M; Gonzalez KD; Vargas HI
Am Surg; 2004 Oct; 70(10):872-5. PubMed ID: 15529840
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intradermal and subcutaneous injections in lymphatic mapping.
Kersey TW; Van Eyk J; Lannin DR; Chua AN; Tafra L
J Surg Res; 2001 Apr; 96(2):255-9. PubMed ID: 11266281
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy in head and neck squamous cell carcinoma.
Pitman KT; Johnson JT; Brown ML; Myers EN
Laryngoscope; 2002 Dec; 112(12):2101-13. PubMed ID: 12461328
[TBL] [Abstract][Full Text] [Related]
7. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM
J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic mapping and sentinel node biopsy in gastric cancer.
Song X; Wang L; Chen W; Pan T; Zhu H; Xu J; Jin M; Finley RK; Wu J
Am J Surg; 2004 Feb; 187(2):270-3. PubMed ID: 14769318
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer.
Levenback C; Coleman RL; Burke TW; Bodurka-Bevers D; Wolf JK; Gershenson DM
Gynecol Oncol; 2001 Nov; 83(2):276-81. PubMed ID: 11606084
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
11. Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram?
Degnim AC; Oh K; Cimmino VM; Diehl KM; Chang AE; Newman LA; Sabel MS
Ann Surg Oncol; 2005 Sep; 12(9):712-7. PubMed ID: 16079955
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic mapping with sentinel node biopsy in pediatric patients.
Neville HL; Andrassy RJ; Lally KP; Corpron C; Ross MI
J Pediatr Surg; 2000 Jun; 35(6):961-4. PubMed ID: 10873044
[TBL] [Abstract][Full Text] [Related]
13. [Lymph nodes mapping for detection of sentinel nodes in patients with papillary thyroid cancer].
Nakano S; Uenosono Y; Ehi K; Arigami T; Higashi Y; Maeda T; Kijima Y; Natsugoe S; Aikou T
Gan To Kagaku Ryoho; 2004 May; 31(5):801-4. PubMed ID: 15170997
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms.
Faries MB; Bleicher RJ; Ye X; Essner R; Morton DL
Arch Surg; 2004 Aug; 139(8):870-6; discussion 876-7. PubMed ID: 15302697
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: A pilot study.
O'Boyle JD; Coleman RL; Bernstein SG; Lifshitz S; Muller CY; Miller DS
Gynecol Oncol; 2000 Nov; 79(2):238-43. PubMed ID: 11063651
[TBL] [Abstract][Full Text] [Related]
16. Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins.
Bostick P; Essner R; Glass E; Kelley M; Sarantou T; Foshag LJ; Qi K; Morton D
Arch Surg; 1999 Jan; 134(1):43-9. PubMed ID: 9927129
[TBL] [Abstract][Full Text] [Related]
17. [Validation of sentinel node in breast cancer].
Vergara-Fernández O; Cortés-González R; Medina-Franco H
Rev Invest Clin; 2004; 56(3):309-13. PubMed ID: 15612512
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.
Thevarajah S; Huston TL; Simmons RM
Am J Surg; 2005 Feb; 189(2):236-9. PubMed ID: 15720998
[TBL] [Abstract][Full Text] [Related]
19. Blue-dye intraoperative sentinel lymph node mapping in early non-small cell lung cancer.
Rzyman W; Hagen OM; Dziadziuszko R; Kobierska-Gulida G; Karmolinski A; Lothe MI; Paleczka W; Murawski M; Jastrzebski T; Kopacz A; Jassem J; Skokowski J
Eur J Surg Oncol; 2006 May; 32(4):462-5. PubMed ID: 16504458
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative hepatic lymphatic mapping in patients with liver metastases from colorectal carcinoma.
Kane JM; Kahlenberg MS; Rodriguez-Bigas MA; Gibbs JF; Petrelli NJ
Am Surg; 2002 Sep; 68(9):745-50. PubMed ID: 12356141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
